Accutane risk management program strengthened.
D000014:Abnormalities, Drug-Induced / Q000517:prevention & control*; D000152:Acne Vulgaris / Q000188:drug therapy*; D000075202:Contraindications; D004345:Drug Industry; D005260:Female; D006801:Humans; D015474:Isotretinoin; D011247:Pregnancy; D011258:Pregnancy Tests; D016730:Program Development; D014481:United States; D014486:United States Food and Drug Administration
D015474:Isotretinoin